*Thrombosis Action Conference (TAC) is a medical education initiative that aims to improve the understanding and management of thromboembolic disorders and evidence-based strategies in the primary prevention and management of thromboembolic disorder.
Agenda:
Day 1:
-What is new in the 2020 ESC guidelines on Atrial Fibrillation
-Patients with AF and Diabetes: Is it possible to avoid irreversible complications?
-Why Kidneys Matter Whilst Preventing Stroke
-Optimizing Protection for AF Patients Undergoing PCI
-Is Oral Anticoagulation Safe and Effective For Use in the Elderly
-AF Patient Case Discussion
Day 2
-Panel Session: Debunking the Myth in AF
-Treatment Challenge in VTE: Exploring Solutions with Rivaroxaban Across Two Clinical Scenarios:
a. What does protection mean for patients with VTE?
b. New Insights for addressing challenges in the management of patient with CAT
-Revolutionising T hrombosis Management with Rivaroxaban in Patients with CAD and PAD